150 related articles for article (PubMed ID: 14519914)
21. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of binders in twin-screw wet granulation - Optimal combination of binder and disintegrant.
Köster C; Kleinebudde P
Eur J Pharm Biopharm; 2023 May; 186():55-64. PubMed ID: 36913991
[TBL] [Abstract][Full Text] [Related]
23. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
Shibata H; Yoshida H; Izutsu K; Goda Y
J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
[TBL] [Abstract][Full Text] [Related]
24. Acid-treated yeast cell wall as a binder displaying function of disintegrant.
Ozeki T; Katsuyama H; Yasuzawa Y; Takashima Y; Kasai T; Eguchi T; Kakiuchi H; Yuasa H; Okada H
AAPS PharmSciTech; 2003; 4(3):E41. PubMed ID: 14621973
[TBL] [Abstract][Full Text] [Related]
25. Tableting and stability evaluation of enteric-coated omeprazole pellets.
Türkoğlu M; Varol H; Celikok M
Eur J Pharm Biopharm; 2004 Mar; 57(2):279-86. PubMed ID: 15018985
[TBL] [Abstract][Full Text] [Related]
26. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
Jung HA; Augsburger LL
Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
[TBL] [Abstract][Full Text] [Related]
27. Fast disintegrating tablets containing Rhodiola rosea L. extract.
Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
[TBL] [Abstract][Full Text] [Related]
29. Formulation design of an oral, fast-disintegrating dosage form containing taste-masked particles of famotidine.
Mizumoto T; Tamura T; Kawai H; Kajiyama A; Itai S
Chem Pharm Bull (Tokyo); 2008 Jul; 56(7):946-50. PubMed ID: 18591807
[TBL] [Abstract][Full Text] [Related]
30. Tensile strength and disintegration of tableted silicified microcrystalline cellulose: influences of interparticle bonding.
Kachrimanis K; Nikolakakis I; Malamataris S
J Pharm Sci; 2003 Jul; 92(7):1489-501. PubMed ID: 12820153
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
Sharma VK
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
[TBL] [Abstract][Full Text] [Related]
32. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant.
Watanabe Y; Koizumi K; Zama Y; Kiriyama M; Matsumoto Y; Matsumoto M
Biol Pharm Bull; 1995 Sep; 18(9):1308-10. PubMed ID: 8845832
[TBL] [Abstract][Full Text] [Related]
33. Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets.
Chono S; Matsui M; Nakamura K; Kasai R
J Pharm (Cairo); 2016; 2016():6131608. PubMed ID: 28044122
[No Abstract] [Full Text] [Related]
34. Effect of polymer, plasticizer and filler on orally disintegrating film.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
[TBL] [Abstract][Full Text] [Related]
35. [Formulation optimization of panax notoginsenoside orally fast disintegration tablets].
Wang Z; Wei L; Chen T
Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(14):1676-80. PubMed ID: 18841763
[TBL] [Abstract][Full Text] [Related]
36. Effects of thermal binders on chemical stabilities and tabletability of gabapentin granules prepared by twin-screw melt granulation.
Kittikunakorn N; Koleng JJ; Listro T; Calvin Sun C; Zhang F
Int J Pharm; 2019 Mar; 559():37-47. PubMed ID: 30660749
[TBL] [Abstract][Full Text] [Related]
37. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method.
Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):175-80. PubMed ID: 16462059
[TBL] [Abstract][Full Text] [Related]
38. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
39. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
Metz DC; Amer F; Hunt B; Vakily M; Kukulka MJ; Samra N
Aliment Pharmacol Ther; 2006 Apr; 23(7):985-95. PubMed ID: 16573801
[TBL] [Abstract][Full Text] [Related]
40. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
